406.04
Overview
News
Price History
Option Chain
Financials
Why ELV Down?
Discussions
Forecast
Stock Split
Dividend History
Elevance Health Inc stock is traded at $406.04, with a volume of 535.84K.
It is up +0.66% in the last 24 hours and up +7.95% over the past month.
Elevance Health remains one of the leading health insurers in the US, providing medical benefits to 45 million medical members at the end of 2025. The company offers employer, individual, and government-sponsored coverage plans. Elevance differs from its peers in its unique position as the largest single provider of Blue Cross Blue Shield branded coverage, operating as the licensee for the Blue Cross Blue Shield Association in 14 states. Through acquisitions, such as the Amerigroup deal in 2012 and MMM in 2021, Elevance's reach expands beyond those states in government-sponsored programs, such as Medicaid and Medicare Advantage plans, too. It is also an emerging player in pharmacy benefit management and other healthcare services.
See More
Previous Close:
$403.04
Open:
$404.83
24h Volume:
535.84K
Relative Volume:
0.36
Market Cap:
$88.06B
Revenue:
$201.11B
Net Income/Loss:
$4.95B
P/E Ratio:
18.05
EPS:
22.4991
Net Cash Flow:
$6.29B
1W Performance:
+0.78%
1M Performance:
+7.95%
6M Performance:
+37.96%
1Y Performance:
+25.86%
Elevance Health Inc Stock (ELV) Company Profile
Name
Elevance Health Inc
Sector
Industry
Phone
(800) 331-1476
Address
220 VIRGINIA AVENUE, INDIANAPOLIS
Compare ELV vs UNH, CVS, CI, HUM
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
ELV
Elevance Health Inc
|
406.04 | 85.94B | 201.11B | 4.95B | 6.29B | 22.50 |
|
UNH
Unitedhealth Group Inc
|
399.83 | 345.44B | 450.13B | 14.91B | 23.62B | 15.55 |
|
CVS
Cvs Health Corp
|
97.20 | 119.78B | 407.94B | 2.90B | 7.39B | 2.2771 |
|
CI
Cigna Group
|
282.69 | 72.51B | 278.13B | 6.74B | 7.66B | 23.60 |
|
HUM
Humana Inc
|
399.88 | 45.72B | 137.20B | 1.15B | 1.27B | 9.3439 |
Elevance Health Inc Stock (ELV) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-08-26 | Initiated | Evercore ISI | In-line |
| Feb-03-26 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Jan-08-26 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Dec-19-25 | Downgrade | Deutsche Bank | Buy → Hold |
| Oct-14-25 | Initiated | Goldman | Neutral |
| Jul-21-25 | Downgrade | Argus | Buy → Hold |
| Jul-18-25 | Downgrade | Leerink Partners | Outperform → Market Perform |
| Apr-15-25 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Mar-17-25 | Upgrade | Argus | Hold → Buy |
| Jan-22-25 | Downgrade | Stephens | Overweight → Equal-Weight |
| Oct-18-24 | Downgrade | Argus | Buy → Hold |
| Jul-18-24 | Downgrade | BofA Securities | Buy → Neutral |
| Jun-24-24 | Initiated | Morgan Stanley | Overweight |
| May-30-24 | Initiated | Robert W. Baird | Outperform |
| Mar-06-24 | Initiated | Barclays | Overweight |
| Jul-12-23 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| Apr-27-23 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Apr-21-23 | Initiated | Cantor Fitzgerald | Overweight |
| Mar-28-23 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Sep-09-22 | Upgrade | BofA Securities | Neutral → Buy |
| Aug-22-22 | Upgrade | SVB Leerink | Mkt Perform → Outperform |
View All
Elevance Health Inc Stock (ELV) Latest News
Elevance Health Inc. stock underperforms Friday when compared to competitors despite daily gains - MarketWatch
$3.6M Anthem denied benefits class action settlement - Top Class Actions
Is UnitedHealth Finding a Better Path to Medicare Advantage Growth? - TradingView
Elevance Health Gets Final OK On $14.75M Nurse OT Deal - Law360
Elevance Health stock draws fresh institutional buying as consensus targets stay above current level - Ad-hoc-news.de
Can Humana's Star Ratings Rebound Unlock MA Earnings Power? - TradingView
Venator Management LLC's Elevance Health Inc(ELV) Holding History - GuruFocus
Elevance Health stock trades around $400 as Q2 2026 earnings beat supports upbeat outlook - Ad-hoc-news.de
UnitedHealth Stock Looks Reasonable at 18.39X P/E: Should You Buy Now? - TradingView
ELV|Elevance Health Inc|Price:399.980|Chg%:+9.740 - TradingKey
Elevance Health Inc. stock outperforms competitors on strong trading day - MarketWatch
Elevance Health stock holds steady as Q2 earnings beat supports 2026 outlook - Ad-hoc-news.de
Elevance Health (ELV) Dips 2.5% to $390.24 Amid Healthcare Sector UncertaintySkew Index - Vinanet
Elevance Health Inc. stock underperforms Monday when compared to competitors - MarketWatch
Elevance Health stock holds at $400 as analysts stay positive - Ad-hoc-news.de
Elevance Health, Inc. (ELV) Stock Analysis: Exploring The 12.18% Potential Upside - DirectorsTalk Interviews
State of Wyoming Takes $1.76 Million Position in Elevance Health, Inc. $ELV - MarketBeat
Stoneridge Investment Partners LLC Acquires New Shares in Elevance Health, Inc. $ELV - MarketBeat
GSA Capital Partners LLP Buys New Holdings in Elevance Health, Inc. $ELV - MarketBeat
Family Legacy Inc. Buys New Stake in Elevance Health, Inc. $ELV - MarketBeat
Empowered Funds LLC Has $6.70 Million Stock Holdings in Elevance Health, Inc. $ELV - MarketBeat
Elevance Health Inc (ELV) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Elevance Health (ELV) Up 6.8% Since Last Earnings Report: Can It Continue? - Yahoo Finance
Mark Cuban Wants Investors Out of Health Insurers. That’s Tough If You Own These ETFs - TradingView
Is Elevance Health (ELV) Still A Bargain After A 38% Gain? - Yahoo Finance
Elevance Health, Inc. (ELV) latest stock news and headlines - Yahoo Finance Singapore
Western Wealth Management LLC Increases Stock Position in Elevance Health, Inc. $ELV - MarketBeat
Can UNH's Lower Medical Costs Sustain the Earnings Recovery? - tradingview.com
Handelsbanken Fonder AB Has $30.86 Million Position in Elevance Health, Inc. $ELV - MarketBeat
NewEdge Advisors LLC Has $5.55 Million Holdings in Elevance Health, Inc. $ELV - marketbeat.com
Chutes & Ladders— Humana names new Medicaid chief; Tufts Medicine CEO, CFO to exit - Fierce Healthcare
Cornerstone Investment Partners, LLC's Elevance Health Inc(ELV) Holding History - GuruFocus
Elevance Health Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
$14.75 Million, 4 Million Documents, One Opt-Out: Nurses’ Overtime Fight With Elevance Health Nears Its End - USA Herald
Hotchkis & Wiley Opportunities Fund's Elevance Health Inc(ELV) Holding History - GuruFocus
Elevance Nurses Seek Final OK Of $14.75M OT Settlement - Law360
Could Elevance Health (NYSE:ELV) Gain From Connected Care? - kalkinemedia.com
Elevance Health, Inc. (ELV) Stock Analysis: Exploring a 13.93% Potential Upside for Investors - DirectorsTalk Interviews
ELV|Elevance Health Inc|Price:394.200|Chg%:+2.860 - TradingKey
Elevance Health, Inc. $ELV Shares Sold by Maj Invest Holding A S - MarketBeat
Professional Advisory Services Inc. Sells 8,231 Shares of Elevance Health, Inc. $ELV - MarketBeat
Assenagon Asset Management S.A. Buys 184,595 Shares of Elevance Health, Inc. $ELV - marketbeat.com
15,573 Shares in Elevance Health, Inc. $ELV Purchased by Renaissance Technologies LLC - marketbeat.com
PensionDanmark Pensionsforsikringsaktieselskab Trims Stock Holdings in Elevance Health, Inc. $ELV - marketbeat.com
Graves Light Lenhart Wealth Inc. Acquires 3,603 Shares of Elevance Health, Inc. $ELV - marketbeat.com
Elevance Health Inc (ELV) Shares Surge 3.5% -- What GF Score of 90 Tells Investors - GuruFocus
Elevance Health Inc. stock outperforms competitors despite losses on the day - MarketWatch
Is Elevance Health (ELV) Entering a Major Earnings Recovery? - Yahoo Finance
Elevance Health, Inc. (ELV) Stock Analysis: Exploring a Potential 19.49% Upside in the Healthcare Sector - DirectorsTalk Interviews
Elevance Health, Inc. $ELV Shares Sold by Alpine Woods Capital Investors LLC - MarketBeat
Empowered Funds LLC Sells 69,221 Shares of Elevance Health, Inc. $ELV - MarketBeat
Elevance Health Inc Stock (ELV) Financials Data
Revenue
Net Income
Cash Flow
EPS
Elevance Health Inc Stock (ELV) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| BOUDREAUX GAIL | President and CEO |
Jul 17 '26 |
Buy |
367.79 |
2,725 |
1,002,230 |
171,976 |
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):